Evidence map›Paper›PMID 19795505›Full record

ReviewGlia2010

Cell-context specific role of the E2F/Rb pathway in development and disease.

Victoria A Swiss, Patrizia Casaccia

Abstract readReview
In one paragraph

Review in Glia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Frontiers in pharmacology · 2026
    Article
  2. Article
  3. The E2F family: a ray of dawn in cardiomyopathy.Molecular and cellular biochemistry · 2025
    Review
  4. Article
  5. bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Victoria A SwissDepartment of Neuroscience and Genetics and Genomics, Mount Sinai School of Medicine, New York, New York 10029, USA.
Patrizia Casaccia

Funding

Role of cell cycle regulators in differentiationR01NS052738 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI CANOLL, PETER, CASACCIA, PATRIZIA · 2007 to 2020
$4.6M
Histone deacetylation in oligodendrocyte differentiationR01NS042925 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI CASACCIA, PATRIZIA · 2003 to 2011
$3.9M
NINDS NIH HHS NS-R0142925NINDS NIH HHS NS-R0152738NINDS NIH HHS R01 NS042925NINDS NIH HHS R01 NS052738
6 · The paper itself

Abstract

Development of the central nervous system (CNS) requires the generation of neuronal and glial cell subtypes in appropriate numbers, and this demands the careful coordination of cell-cycle exit, survival, and differentiation. The E2F/Rb pathway is critical for cell-cycle regulation and also modulates survival and differentiation of distinct cell types in the developing and adult CNS. In this review, we first present the specific temporal patterns of expression of the E2F and Rb family members during CNS development and then discuss the genetic ablation of single or multiple members of these two families. Overall, the available data suggest a time-dependent and cell-context specific role of E2F and Rb family members in the developing and adult CNS.

Indexed as

AnimalsCentral Nervous SystemCentral Nervous System DiseasesE2F Transcription FactorsHumansRetinoblastoma ProteinSignal TransductionE2F Transcription FactorsRetinoblastoma Protein

Identifiers

PMID19795505
PMCPMC2882865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.